The Pulmonary Drug Delivery Systems Market is estimated to be valued at Us$ 34.34 Bn or Mn in 2023 and is expected to exhibit a CAGR Of 4.6% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pulmonary drug delivery systems are devices used for direct delivery of drugs to the lungs for local and systemic action. It...